ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® GI 2024 Insights: "EMERALD-1 Trial - The Combination Therapy of Durvalumab + Bevacizumab, With TACE, for Unresectable HCC"
By
ecancer
FEATURING
Riccardo Lencioni
By
ecancer
FEATURING
Riccardo Lencioni
Comments 0
Login to view comments.
Click here to Login
